AQST Earnings

Quarterly EPS
$-0.13
Q3 2024
$-0.19
Q4 2024
$-0.24
Q1 2025
$-0.14
Q2 2025
$-0.14
Q3 2025
$-0.26
Q4 2025
$-0.07
Q1 2026
$-0.18
Q2 2026
Latest Revenue13.8M
Latest Net Income-22864000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.1813.8M-22864000+38.1%-28.6%
Q1 2026-$0.0714.4M-8057000+65.7%+70.8%
Q4 2025-$0.2613.0M-31860000+9.7%-36.8%
Q3 2025-$0.1412.8M-15446000-5.4%-7.7%
Q2 2025-$0.1410.0M-13548000-50.2%-366.7%
Q1 2025-$0.248.7M-22930000-27.7%-41.2%
Q4 2024-$0.1911.9M-17055000-10.1%-58.3%
Q3 2024-$0.1313.5M-11509000+4.2%-333.3%
Q2 2024-$0.0320.1M-2745000
Q1 2024-$0.1712.1M-12828000
Q4 2023-$0.1213.2M-8111000
Q3 2023-$0.0313.0M-2035000
Aquestive Therapeutics (AQST) — Earnings